Este compuesto es un derivado sintético lipídico que puede administrarse oralmente, con un perfil de seguridad sobresaliente y que presenta resultados prometedores en pacientes con tumores sólidos ...
Read moreAgomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors as Asabys.
Read moreOryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the nine months...
Read moreThe digital health technology revolution is not just a trend; it’s reshaping patient care and pharma engagement right now.
Read moreMineralys Therapeutics today announced that it has completed enrollment in the Launch-HTN trial ahead of schedule. Launch-HTN is the second of two trials under the planned pivotal program evaluating t...
Read moreThe research community recognizes the arrival of artificial intelligence (AI) as a revolution, a “paradigm shift” that affects all areas of research.
Read moreActive participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.
Read moreBiointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...
Read moreThe phase II SERENA-2 randomized, multi-dose clinical trial compared the efficacy of next-generation SERD camizestrant (developed by AstraZeneca) with fulvestrant.
Read moreLaminar Pharma es una empresa biotecnológica española que está desarrollando su principal compuesto LAM561, un derivado sintético del ácido oleico que puede ingerirse por vía oral. Este fármaco...
Read more“How do we break the walls of realizing the full potential of organoids and microtissues as an alternative to animal testing?” In line with the motto of the Falling Walls Science Summit 2024 in Be...
Read moreEl Proyecto Macaon, desarrollado por investigadores del IMIBIC, el Hospital Reina Sofía y la Universidad de Córdoba en colaboración con la industria farmacéutica, ha alcanzado un importante hito e...
Read more